<img alt="" height="1" width="1" />AGI losses narrowed as costs cutRTE.ieLast year, AGI halted its programme to develop the Rezular irritable bowel syndrome treatment after disappointing trial results. ...<nobr>and more »</nobr> |
<img alt="" height="1" width="1" />AGI losses narrowed as costs cutRTE.ieLast year, AGI halted its programme to develop the Rezular irritable bowel syndrome treatment after disappointing trial results. ...<nobr>and more »</nobr> |